Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction

PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

February 28, 2006

Conditions
Myocardial Infarction
Interventions
DRUG

TNK-tPA

DRUG

rt-PA

Trial Locations (18)

100029

Beijing An Zhen Hospital, Beijing

100044

Beijing University, Beijing

100050

Beijing Friendship Hospital, Beijing

Beijing Xuan Wu Hospital, Beijing

100730

Bejing Tongren Hospital, Beijing

100744

Seoul National University Hospital, Seoul

110015

People's Hospital of Liaoning Province, Shenyang

116033

Center Hospital of Dalian, Dalian

120752

Yonsei University Severance Hospital, Seoul

138736

Seoul Joongang Hospital, Seoul

200032

Fudan University, Shanghai

250013

Center Hospital of Jinan, Jinan

443721

A-Jou University Hospital, Suwon

501757

Chunnam University Hospital, Kwangju

602715

Dong-A University Hospital, Pusan

700711

Dongsan Medical Center, Jung-Ku

Unknown

The University of Hong Kong, Cardiology Division, Hong Kong

Wonju Christian Hospital (Yonsei University Hosp), Wŏnju

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY